As of 2025-11-04, the Relative Valuation of Zentalis Pharmaceuticals Inc (ZNTL) is (63.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.44 USD, the upside of Zentalis Pharmaceuticals Inc based on Relative Valuation is -4511.1%.
The range of the Relative Valuation is (57.22) - (79.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 35.3x | 24.1x |
| Forward P/E multiples | 25.4x - 37.0x | 32.2x |
| Fair Price | (57.22) - (79.56) | (63.52) |
| Upside | -4073.9% - -5625.3% | -4511.1% |
| Date | P/E |
| 2025-11-03 | -0.64 |
| 2025-10-31 | -0.66 |
| 2025-10-30 | -0.66 |
| 2025-10-29 | -0.68 |
| 2025-10-28 | -0.76 |
| 2025-10-27 | -0.76 |
| 2025-10-24 | -0.76 |
| 2025-10-23 | -0.73 |
| 2025-10-22 | -0.72 |
| 2025-10-21 | -0.73 |
| 2025-10-20 | -0.69 |
| 2025-10-17 | -0.66 |
| 2025-10-16 | -0.69 |
| 2025-10-15 | -0.70 |
| 2025-10-14 | -0.68 |
| 2025-10-13 | -0.72 |
| 2025-10-10 | -0.74 |
| 2025-10-09 | -0.80 |
| 2025-10-08 | -0.73 |
| 2025-10-07 | -0.69 |
| 2025-10-06 | -0.70 |
| 2025-10-03 | -0.71 |
| 2025-10-02 | -0.74 |
| 2025-10-01 | -0.68 |
| 2025-09-30 | -0.67 |
| 2025-09-29 | -0.66 |
| 2025-09-26 | -0.69 |
| 2025-09-25 | -0.66 |
| 2025-09-24 | -0.67 |
| 2025-09-23 | -0.66 |
| 2025-09-22 | -0.67 |
| 2025-09-19 | -0.67 |
| 2025-09-18 | -0.66 |
| 2025-09-17 | -0.63 |
| 2025-09-16 | -0.63 |
| 2025-09-15 | -0.64 |
| 2025-09-12 | -0.66 |
| 2025-09-11 | -0.69 |
| 2025-09-10 | -0.65 |
| 2025-09-09 | -0.71 |
| 2025-09-08 | -0.72 |
| 2025-09-05 | -0.78 |
| 2025-09-04 | -0.78 |
| 2025-09-03 | -0.76 |
| 2025-09-02 | -0.76 |
| 2025-08-29 | -0.75 |
| 2025-08-28 | -0.78 |
| 2025-08-27 | -0.81 |
| 2025-08-26 | -0.82 |
| 2025-08-25 | -0.81 |